FDA NDC Directory · JSON-LD · Markdown

Nucala

NDC 0173-0892 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namemepolizumab
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryBiologic License Application · App BLA761122
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsMEPOLIZUMAB (100 mg/mL)
Marketing started20190606
Package count4

External sources

Source: openFDA. Public-domain (CC0).